| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.034 | 0.5 |